AAAAAA

   
Results: 1-11 |
Results: 11

Authors: ZHONG WZ SANDERS PE HAUER MJ VRBANAC JJ
Citation: Wz. Zhong et al., QUANTITATIVE-ANALYSIS QUANTITATION OF 2-N-NONYL-1,3-DIOXOLANE BY STABLE-ISOTOPE DILUTION GAS-CHROMATOGRAPHY MASS-SPECTROMETRY, Journal of chromatography B. Biomedical sciences and applications, 705(1), 1998, pp. 39-45

Authors: VOORMAN RL MAIO SM HAUER MJ SANDERS PE PAYNE NA ACKLAND MJ
Citation: Rl. Voorman et al., METABOLISM OF DELAVIRDINE, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE INHIBITOR, BY MICROSOMAL CYTOCHROME-P450 IN HUMANS, RATS, AND OTHER SPECIES - PROBABLE INVOLVEMENT OF CYP2D6 AND CYP3A, Drug metabolism and disposition, 26(7), 1998, pp. 631-639

Authors: WYNALDA MA HAUER MJ WONKERS LC
Citation: Ma. Wynalda et al., HUMAN BIOTRANSFORMATION OF BROPIRIMINE - CHARACTERIZATION OF THE MAJOR BROPIRIMINE OXIDATIVE METABOLITES FORMED IN-VITRO, Drug metabolism and disposition, 26(10), 1998, pp. 1048-1051

Authors: WIENKERS LC STEENWYK RC HAUER MJ FLEISHAKER JC PEARSON PG
Citation: Lc. Wienkers et al., BIOTRANSFORMATION OF TIRILAZAD IN HUMAN - 3 - TIRILAZAD A-RING REDUCTION BY HUMAN LIVER MICROSOMAL 5-ALPHA-REDUCTASE TYPE-1 AND TYPE-2, The Journal of pharmacology and experimental therapeutics, 287(2), 1998, pp. 583-590

Authors: CHANG M SOOD VK KLOOSTERMAN DA HAUER MJ FAGERNESS PE SANDERS PE VRBANAC JJ
Citation: M. Chang et al., IDENTIFICATION OF THE METABOLITES OF THE HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR DELAVIRDINE IN MONKEYS, Drug metabolism and disposition, 25(7), 1997, pp. 814-827

Authors: CHANG M SOOD VK WILSON GJ KLOOSTERMAN DA SANDERS PE HAUER MJ ZHANG WR BRANSTETTER DG
Citation: M. Chang et al., METABOLISM OF THE HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR DELAVIRDINE IN MICE, Drug metabolism and disposition, 25(7), 1997, pp. 828-839

Authors: CHANG M SOOD VK WILSON GJ KLOOSTERMAN DA SANDERS PE HAUER MJ FAGERNESS PE
Citation: M. Chang et al., METABOLISM OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE INHIBITOR DELAVIRDINE IN RATS, Drug metabolism and disposition, 25(2), 1997, pp. 228-242

Authors: SLATTER JG FEENSTRA KL HAUER MJ SANDERS PE VRBANAC JJ SCOTT G SPEED W
Citation: Jg. Slatter et al., METABOLISM OF A BISPHOSPHONATE ESTER (PNU-91638) IN RAT, Xenobiotica, 27(10), 1997, pp. 1039-1051

Authors: ZHAO ZY KOEPLINGER KA PADBURY GE HAUER MJ BUNDY GL BANITT LS SCHWARTZ TM ZIMMERMANN DC HARBACH PR MAYO JK AARON CS
Citation: Zy. Zhao et al., BIOACTIVATION OF -2,4-DI-1-PYRROLIDINYL-7H-PYRROLO[2,3-D]PYRIMIDINE (U-89843) TO REACTIVE INTERMEDIATES THAT BIND COVALENTLY TO MACROMOLECULES AND PRODUCE GENOTOXICITY, Chemical research in toxicology, 9(8), 1996, pp. 1230-1239

Authors: ZHAO ZY KOEPLINGER KA BUNDY GL BANITT LS PADBURY GE HAUER MJ SANDERS PE
Citation: Zy. Zhao et al., IN-VITRO AND IN-VIVO BIOTRANSFORMATION OF -2,4-DI-1-PYRROLIDINYL-7H-PYRROLO[2,3-D]PYRIMIDINE (U-89843) IN THE RAT, Drug metabolism and disposition, 24(2), 1996, pp. 187-198

Authors: SLATTER JG FEENSTRA KL HAUER MJ KLOOSTERMAN DA PARTON AH SANDERS PE SCOTT G SPEED W
Citation: Jg. Slatter et al., METABOLISM OF THE BISPHOSPHONATE ESTER U-91502 IN RATS, Drug metabolism and disposition, 24(1), 1996, pp. 65-73
Risultati: 1-11 |